Lai-Ming Ching Selected Research

Lai-Ming Ching Research Topics

Disease

28	Neoplasms (Cancer) 01/2021 - 01/2002
10	Necrosis 03/2014 - 03/2004
4	Multiple Myeloma 09/2004 - 05/2003
2	Glioma (Gliomas) 11/2018 - 03/2014
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 08/2010
2	Hypoxia (Hypoxemia) 04/2014 - 08/2006
2	Mesothelioma 04/2010 - 12/2005
2	Adenocarcinoma 06/2009 - 08/2005
2	Lung Neoplasms (Lung Cancer) 03/2008 - 12/2005
1	Breast Neoplasms (Breast Cancer) 09/2020
1	Carcinoma (Carcinomatosis) 09/2020
1	Circulating Neoplastic Cells 09/2020
1	Cataract (Cataracts) 09/2015
1	Wounds and Injuries (Trauma) 04/2014
1	Chronic Disease (Chronic Diseases) 04/2014
1	Glioblastoma (Glioblastoma Multiforme) 03/2014
1	Pre-Eclampsia (Preeclampsia) 05/2010
1	Vascular System Injuries 06/2009
1	Adenocarcinoma of Lung 03/2008
1	Thymoma (Thymic Carcinoma) 07/2007
1	Inflammation (Inflammations) 08/2006
1	Lymphoma (Lymphomas) 01/2005

Drug/Important Bio-Agent (IBA)

21	vadimezanIBA 03/2014 - 01/2002
8	CytokinesIBA 11/2011 - 01/2002
5	Thalidomide (Thalomid)FDA Link 09/2004 - 09/2002
4	Tryptophan (L-Tryptophan)FDA Link 01/2021 - 03/2013
4	NF-kappa B (NF-kB)IBA 04/2010 - 01/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2007 - 08/2005
3	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2021 - 03/2013
3	EnzymesIBA 01/2021 - 03/2013
3	Pharmaceutical PreparationsIBA 08/2006 - 01/2002
2	AntigensIBA 09/2020 - 07/2007
2	AcidsIBA 03/2014 - 08/2005
2	ChemokinesIBA 11/2011 - 08/2009
2	Proteins (Proteins, Gene)FDA Link 08/2010 - 04/2010
1	Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 09/2020
1	Cell-Free Nucleic AcidsIBA 09/2020
1	Biomarkers (Surrogate Marker)IBA 09/2020
1	Volatile Organic CompoundsIBA 09/2020
1	DNA (Deoxyribonucleic Acid)IBA 09/2020
1	Nucleic AcidsIBA 09/2020
1	Estrogens (Estrogen)FDA Link 01/2018
1	CalreticulinIBA 01/2018
1	Hormones (Hormone)IBA 01/2018
1	KynurenineIBA 09/2015
1	ConnexinsIBA 04/2014
1	Angiogenesis InhibitorsIBA 04/2014
1	Bevacizumab (Avastin)FDA Link 03/2014
1	LuciferasesIBA 03/2014
1	UbiquitinIBA 08/2010
1	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2010
1	A-factor (Streptomyces)IBA 05/2010
1	NLR ProteinsIBA 04/2010
1	Phosphotransferases (Kinase)IBA 04/2010
1	Chemokine CXCL10IBA 04/2010
1	Messenger RNA (mRNA)IBA 04/2010
1	Small Interfering RNA (siRNA)IBA 04/2010
1	Biological ProductsIBA 04/2010
1	LigandsIBA 04/2010
1	xanthoneIBA 04/2010
1	rofecoxib (Vioxx)FDA Link 06/2009
1	Ibuprofen (Motrin)FDA LinkGeneric 06/2009
1	Celecoxib (Celebrex)FDA Link 06/2009
1	ProstaglandinsIBA 06/2009
1	Diclofenac (SR 38)FDA LinkGeneric 06/2009
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 06/2009
1	SalicylatesIBA 06/2009
1	OvalbuminIBA 07/2007
1	combretastatinIBA 07/2007
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2007
1	PerforinIBA 12/2005
1	Evans Blue (Blue, Evans)FDA Link 08/2005
1	Serotonin (5 Hydroxytryptamine)IBA 08/2005
1	Type I Tumor Necrosis Factor ReceptorsIBA 08/2005
1	AlbuminsIBA 08/2005
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 08/2005
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2004
1	Interferon-gamma (Interferon, gamma)IBA 03/2004
1	Therapeutic UsesIBA 05/2003
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2003
1	SiliconIBA 01/2002

Therapy/Procedure

3	Therapeutics 04/2014 - 05/2003
3	Drug Therapy (Chemotherapy) 03/2008 - 09/2002
1	Radiotherapy 04/2014
1	Immunotherapy 08/2006
1	Aftercare (After-Treatment) 01/2003